• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

  • — 5 Nov, 2007
AudioMedica News
AudioMedica News
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
00:00 /
RSS Feed
Share
Link
Embed
Laura Mauri
Laura Mauri
Raymond Gibbons
Raymond Gibbons

REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota

The largest study to date looking at long-term outcomes of bare metal stents as compared with drug eluting stents in patients who have undergone PCI was presented to the American Heart Association annual meeting. There was no increased mortality for patients who received drug eluting stents in a Massachussets based population. Sarah Maxwell spoke with investigator to Laura Mauri at the Orlando meeting.

[audio:https://www.audiomedica.com/podcasting/cardio/071104MauriGibbonsPODCAST.mp3]

You may also like...

  • Drug-eluting Stents: Cost-Benefit Targeting? Drug-eluting Stents: Cost-Benefit Targeting? 12 Sep, 2005
  • Looking for Atherosclerosis in the Legs Could Save Lives Looking for Atherosclerosis in the Legs Could Save Lives 5 Sep, 2007
  • Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 15 Nov, 2006
  • Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results 6 Nov, 2007
  • Previous story Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
  • Next story Eptifibatide After PCI: Brief Infusion Is Just As Good
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • New Front Line Standard for Older Patients with Chronic…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Cardiovascular
  • Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.